Search in:

Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

Minodronate for the treatment of osteoporosis

Tsuyoshi Ohishi1 Department of Orthopaedic Surgery, Enshu Hospital, Hamamatsu, Shizuoka, JapanCorrespondence[email protected]

Yukihiro Matsuyama2 Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

Pages 729-739 | Published online: 17 Apr 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Mikkel Bo Brent. (2023) Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies. Pharmacology & Therapeutics 244, pages 108383.
Crossref

Takuya Morinishi, Aya Nawata, Ryo Konishi, Erina Ono, Koji Takaori & Sayako Maeda. (2021) Nephrotic syndrome with acute kidney injury due to focal segmental glomerulosclerosis following long-term treatment with minodronate. CEN Case Reports 11:1, pages 120-125.
Crossref

Masashi Hirota, Tsuyoshi Takahashi, Yurina Saito, Ryohei Kawabata, Rie Nakatsuka, Hiroshi Imamura, Masaaki Motoori, Yoichi Makari, Atsushi Takeno, Kentaro Kishi, Shinichi Adachi, Hiromichi Miyagaki, Yukinori Kurokawa, Makoto Yamasaki, Hidetoshi Eguchi & Yuichiro Doki. (2021) Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials. Annals of Gastroenterological Surgery 5:6, pages 754-766.
Crossref

Andrea Spinaci, Michela Buccioni, Diego Dal Ben, Gabriella Marucci, Rosaria Volpini & Catia Lambertucci. (2021) P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications. Frontiers in Pharmacology 12.
Crossref

Agnieszka Wiesner, Mariusz Szuta, Agnieszka Galanty & Paweł Paśko. (2021) Optimal Dosing Regimen of Osteoporosis Drugs in Relation to Food Intake as the Key for the Enhancement of the Treatment Effectiveness—A Concise Literature Review. Foods 10:4, pages 720.
Crossref

Sandip Kumar Baidya, Sk. Abdul Amin & Tarun Jha. (2021) Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-present. European Journal of Medicinal Chemistry 213, pages 113044.
Crossref

Jéssica S. Barbosa, Filipe A. Almeida Paz & Susana Santos Braga. (2021) Bisphosphonates, Old Friends of Bones and New Trends in Clinics. Journal of Medicinal Chemistry 64:3, pages 1260-1282.
Crossref

Masaki Kobayashi, Kenjiro Sawada, Akihiko Yoshimura, Misa Yamamoto, Aasa Shimizu, Kotaro Shimura, Naoko Komura, Mayuko Miyamoto, Kyoso Ishida & Tadashi Kimura. (2020) Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study. BMC Women's Health 20:1.
Crossref

Aurélie Gernet, Nicolas Sevrain, Jean-Noël Volle, Tahar Ayad, Jean-Luc Pirat & David Virieux. (2020) Diversity-Oriented Synthesis toward Aryl- and Phosphoryl-Functionalized Imidazo[1,2- a ]pyridines . The Journal of Organic Chemistry 85:22, pages 14730-14743.
Crossref

T. Yoshida, H. Kinoshita, H. Taniguchi, M. Yanishi, M. Sugi & T. Matsuda. (2020) A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study. Osteoporosis International 31:7, pages 1251-1259.
Crossref

Vasileios Alexandros Karakousis, Danai Liouliou, Aikaterini Loula, Nikoleta Kagianni, Eva-Maria Dietrich, Soultana Meditskou, Antonia Sioga & Theodora Papamitsou. (2020) Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration. Medicina 56:3, pages 140.
Crossref

Qingshan Liu, Dongmei Chen, Zongjian Ye, Zhaoming Jin, Tao Ma & Xuemei Huang. (2020) Minodronate in the treatment of osteoporosis. Medicine 99:40, pages e22542.
Crossref

Yuan-Zhe Jin, Jae Hyup Lee, Bin Xu & Minjoon Cho. (2019) Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders 20:1.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Minodronate for the treatment of osteoporosis

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Minodronate for the treatment of osteoporosis

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date